Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease

Authors: Mojgan Golzy, Russell W Bessette, Randy L Carter

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Chronic kidney disease is associated with disruption of the endocrine system that distorts the balance between calcitriol, calcium, phosphate and parathyroid hormone in the calcium regulation system. This can lead to calcification of the arterial tree and increased risk of cardiovascular disease and death. In this study we develop a health metric, based on biomarkers involved in the calcium regulation system, for use in identifying patients at high risk for future high-cost complications.

Methods

This study is a retrospective observational study involving a secondary analysis of data from the kidney disease registry of a regional managed care organization. Chronic kidney disease patients in the registry from November 2007 through November 2011 with a complete set of observations of estimated glomerular filtration rate, calcitriol, albumin, free calcium, phosphate, and parathyroid hormone were included in the study (n = 284). Weibull regression model was used to identify the most significant lab tests in predicting “waiting time to hospitalization”. A multivariate linear path model was then constructed to investigate direct and indirect effects of the biomarkers on this outcome.

Results

The results showed negative significant direct effects of phosphate and parathyroid hormone on “waiting time to hospitalization”. Base on this result, the risk of hospitalization increases 16.8% for each 0.55 mg/dl increase in phosphate level and 13.5% for each 0.467 increase in the natural logarithm of parathyroid hormone. Positive indirect effects of calcitriol surrogate (calcidiol), free calcium, albumin and estimated glomerular filtration rate were observed but were relatively small in magnitude.

Conclusion

Variables involved in the calcium regulation system should be included in future efforts to develop a quality of care index for Chronic Kidney disease patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Block GA, Hulbert-Shearon TE, Levin NW: Association of serum phosphorous and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998, 31: 607-617. 10.1053/ajkd.1998.v31.pm9531176.CrossRefPubMed Block GA, Hulbert-Shearon TE, Levin NW: Association of serum phosphorous and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998, 31: 607-617. 10.1053/ajkd.1998.v31.pm9531176.CrossRefPubMed
2.
go back to reference Teng M, Wolf M, Ofsthun MN: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J. Am Soc Nephrol. 2005, 16: 1115-1125. 10.1681/ASN.2004070573.CrossRefPubMed Teng M, Wolf M, Ofsthun MN: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J. Am Soc Nephrol. 2005, 16: 1115-1125. 10.1681/ASN.2004070573.CrossRefPubMed
3.
go back to reference Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T: Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int Suppl. 1999, 73: S2-S7.CrossRefPubMed Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T: Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int Suppl. 1999, 73: S2-S7.CrossRefPubMed
4.
go back to reference Souberbielle J. P, Roth H, Fouque D. P: parathyroid hormone measurement in CKD. Kidney Int. 2010, 77 (2): 93-100 Epub 2009 Oct 7. 10.1038/ki.2009.374.CrossRefPubMed Souberbielle J. P, Roth H, Fouque D. P: parathyroid hormone measurement in CKD. Kidney Int. 2010, 77 (2): 93-100 Epub 2009 Oct 7. 10.1038/ki.2009.374.CrossRefPubMed
5.
go back to reference Vanholder R, Massy Z, Argiles A: Chronic Kidney disease as a cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005, 20: 1048-1056. 10.1093/ndt/gfh813.CrossRefPubMed Vanholder R, Massy Z, Argiles A: Chronic Kidney disease as a cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005, 20: 1048-1056. 10.1093/ndt/gfh813.CrossRefPubMed
6.
go back to reference Foley RN, Parfrey Ps, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32 (S1): 12-19. Foley RN, Parfrey Ps, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32 (S1): 12-19.
7.
go back to reference Sarnak MJ: Cardiovascular complications in chronic kidney disease. Am J kidney Dis. 2003, 41: 11-17.CrossRefPubMed Sarnak MJ: Cardiovascular complications in chronic kidney disease. Am J kidney Dis. 2003, 41: 11-17.CrossRefPubMed
8.
go back to reference Palmer SC, Hayen A, Macaskill P: Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with Chronic Kidney disease. A systematic review and meta-analysis. JAMA. 2011, 305 (11): 1119-1127. 10.1001/jama.2011.308.CrossRefPubMed Palmer SC, Hayen A, Macaskill P: Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with Chronic Kidney disease. A systematic review and meta-analysis. JAMA. 2011, 305 (11): 1119-1127. 10.1001/jama.2011.308.CrossRefPubMed
14.
go back to reference Nordin BEC, Need AG: The relation between serum calcidiol and calcitriol. BoneKEy-Osteovision. 2005, 2 (5): 7-16. 10.1138/20050160.CrossRef Nordin BEC, Need AG: The relation between serum calcidiol and calcitriol. BoneKEy-Osteovision. 2005, 2 (5): 7-16. 10.1138/20050160.CrossRef
15.
go back to reference Isselbacher: HarrisonŠs Principles of Internal Medicine. 1994, NY McGraw-Hill 13th Ed. Vol. 2. P. 2139. Isselbacher: HarrisonŠs Principles of Internal Medicine. 1994, NY McGraw-Hill 13th Ed. Vol. 2. P. 2139.
16.
go back to reference Sava L, Pillai S, More U, Sontakke A: Serum calcium measurement: total versus free (ionized) calcium. Indian J Clin Biochem. 2005, 20 (2): 158-161. 10.1007/BF02867418.CrossRefPubMedPubMedCentral Sava L, Pillai S, More U, Sontakke A: Serum calcium measurement: total versus free (ionized) calcium. Indian J Clin Biochem. 2005, 20 (2): 158-161. 10.1007/BF02867418.CrossRefPubMedPubMedCentral
17.
go back to reference Morton AR, Garland JS: Holden RM: Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial. 2010, 23 (3): 283-289. 10.1111/j.1525-139X.2010.00735.x.CrossRefPubMed Morton AR, Garland JS: Holden RM: Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial. 2010, 23 (3): 283-289. 10.1111/j.1525-139X.2010.00735.x.CrossRefPubMed
18.
go back to reference Klein JP, Moeschberger ML: Survival Analysis Techniques for Censored and Truncated Data. 1997, New York: Springer Klein JP, Moeschberger ML: Survival Analysis Techniques for Censored and Truncated Data. 1997, New York: Springer
20.
go back to reference Wright S: Correction and causation. J Agric Resour. 1921, 20: 54-110. Wright S: Correction and causation. J Agric Resour. 1921, 20: 54-110.
21.
go back to reference Wright S: The method of path coefficient. Ann Math Stat. 1934, 5: 161-215. 10.1214/aoms/1177732676.CrossRef Wright S: The method of path coefficient. Ann Math Stat. 1934, 5: 161-215. 10.1214/aoms/1177732676.CrossRef
22.
go back to reference Pak Y: Multivariate linear path models. Ph.D. dissertation,. University at Buffalo, Department of Biostatistics, 2007 Pak Y: Multivariate linear path models. Ph.D. dissertation,. University at Buffalo, Department of Biostatistics, 2007
24.
go back to reference Casella G, Berger RL: Statistical Inferenc,. 2001, Pacific Grove: Duxbury Press, Brooks/Cole Publishing Company Casella G, Berger RL: Statistical Inferenc,. 2001, Pacific Grove: Duxbury Press, Brooks/Cole Publishing Company
25.
go back to reference Kutner M, Nachtsheim C, Neter J, Li W: Applied Linear Statistical Models. 2004, New York: McGraw-Hill/Irwin Kutner M, Nachtsheim C, Neter J, Li W: Applied Linear Statistical Models. 2004, New York: McGraw-Hill/Irwin
26.
go back to reference Kent J, O’Quigley J: Measures of dependence for censored survival data. Biometrika. 1988, 75 (3): 525-534. 10.1093/biomet/75.3.525.CrossRef Kent J, O’Quigley J: Measures of dependence for censored survival data. Biometrika. 1988, 75 (3): 525-534. 10.1093/biomet/75.3.525.CrossRef
27.
go back to reference Feehalby J, Fledge J, Johnson R: Comprehensive Clinical Nephrology;. Maryland Heights: Mosby Press; 2007:123–140. Chapter 10 Feehalby J, Fledge J, Johnson R: Comprehensive Clinical Nephrology;. Maryland Heights: Mosby Press; 2007:123–140. Chapter 10
28.
go back to reference Beddhu S, Ma X, Baird B, et al: Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (11): 1805-1810. 10.2215/CJN.01560309.CrossRefPubMedPubMedCentral Beddhu S, Ma X, Baird B, et al: Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (11): 1805-1810. 10.2215/CJN.01560309.CrossRefPubMedPubMedCentral
29.
go back to reference Seiler S, Heine GH, Fliser D: Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int Suppl. 2009, 114: S34-S42.CrossRefPubMed Seiler S, Heine GH, Fliser D: Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int Suppl. 2009, 114: S34-S42.CrossRefPubMed
Metadata
Title
Renal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease
Authors
Mojgan Golzy
Russell W Bessette
Randy L Carter
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-154

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.